Study for Characterisation of Predictive Parameters of Clonal Evolution in Subjects With GATA2 Germline Mutation

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

December 7, 2023

Primary Completion Date

December 31, 2033

Study Completion Date

December 31, 2033

Conditions
GATA2 Gene Mutation
Interventions
OTHER

Biological samples (blood and bone marrow samples).

For each included patient, biological samples (blood and bone marrow samples) will be collected at baseline visit and then during 5 years, according to the samples taken in the standard practice. No additional sampling will be performed for the study.

Trial Locations (19)

Unknown

RECRUITING

CHU Angers, Angers

RECRUITING

CHU Bordeaux, Bordeaux

RECRUITING

CHU Estaing, Clermont-Ferrand

RECRUITING

CHU Dijon, Dijon

RECRUITING

CHRU - Lille, Lille

RECRUITING

IHOP Lyon, Lyon

NOT_YET_RECRUITING

CHU La Timone, Marseille

RECRUITING

CHU Arnaud de Villeneuve, Montpellier

RECRUITING

CHU Nantes, Nantes

RECRUITING

Hôpital Armand Trousseau, Paris

RECRUITING

Hôpital Robert Debré, Paris

RECRUITING

Hôpital Saint-Louis, Paris

RECRUITING

CHU Rennes, Rennes

RECRUITING

CHU Hôpitaux de Rouen - Charles Nicolle, Rouen

RECRUITING

CHU Saint-Etienne, Saint-Priest-en-Jarez

RECRUITING

CHU Strasbourg, Strasbourg

RECRUITING

CHU Purpan - Hôpital des Enfants, Toulouse

RECRUITING

Institut Universitaire Du Cancer Toulouse - Oncopole (Iuct-O), Toulouse

RECRUITING

CHRU Nancy Hôpital d'enfants, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Institut Claudius Regaud

OTHER